Florida-based businessman Danny Gaekwad seeks Trump administration intervention after lack of response from Indian regulators ...

A division bench of the Delhi High Court on Thursday rejected an appeal by Dr. Rashmi Saluja, the Executive Chairman of ...

The court directed Sebi to decide on US resident Digvijay ‘Danny’ Gaekwad’s proposed competing offer in accordance with the ...

Hamid Ahmed, CEO of Hamdard Laboratories India, has resigned as an independent director from Religare Enterprises due to ...

Gaekwad sought for a special exemption under takeover from the Securities and Exchange Board of India to make an open offer ...

Hamid Ahmed, CEO of Hamdard Laboratories India, has resigned from Religare Enterprises' board due to increasing workload in his family business. The resignation comes amidst a contentious open offer ...

The Delhi High Court has allowed the Burman family's open offer for acquiring a stake in Religare Enterprises Ltd to proceed, ...

While declining interim relief, the court directed SEBI to swiftly decide on a competing takeover bid, keeping the stage set ...

Net Sales at Rs 1,664.43 crore in December 2024 up 10.19% from Rs. 1,510.58 crore in December 2023. Quarterly Net Loss at Rs.

Delhi High Court rejects plea to block investors from voting on Rashmi Saluja's re-appointment, allows Burmans' open offer.

Orbimed Genesis Master Fund L.P. bought 45,000 shares of Mankind Pharma at Rs 2,555.1 per share, while Copthall Mauritius ...

A Religare Enterprises minority shareholder has filed an appeal against a Delhi High Courts single judges order that refused ...